Holen Sie sich die Stockscreener-App
49.21
1.88%
0.91
Vorhandelsmarkt:
50.00
0.79
+1.61%
Schlusskurs vom Vortag:
$48.30
Offen:
$48.68
24-Stunden-Volumen:
316.43K
Relative Volume:
0.67
Marktkapitalisierung:
$2.67B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$23.68M
KGV:
117.17
EPS:
0.42
Netto-Cashflow:
$108.67M
1W Leistung:
+3.32%
1M Leistung:
+3.40%
6M Leistung:
-6.99%
1J Leistung:
-2.07%
1-Tages-Spanne:
$48.41
$49.26
1-Wochen-Bereich:
$47.23
$49.26
52-Wochen-Spanne:
$43.15
$64.47
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
49.21 | 2.67B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
LivaNova Sets Date for Q4 and Full-Year 2024 Earnings Release and Conference Call - StockTitan
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - The Bakersfield Californian
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova Becomes Oversold (LIVN) - Nasdaq
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Vagus Nerve Stimulators Market Report Analysis and Research - openPR
LivaNova's Depression Treatment Study Shows Promise Despite Mixed Clinical Results - StockTitan
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression - Business Wire
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to "Strong-Buy" - MarketBeat
State Street Corp Cuts Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Fmr LLC Has $1.65 Million Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
When (LIVN) Moves Investors should Listen - Stock Traders Daily
LivaNova's SWOT analysis: sleep apnea platform could awaken stock potential - Investing.com India
Jane Street Group LLC Sells 19,525 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Barclays PLC - MarketBeat
XTX Topco Ltd Invests $550,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Insider Sell: Francesco Bianchi Sells 1,250 Shares of LivaNova P - GuruFocus.com
Key Factors Shaping the Medical Implants Market: Trends - openPR
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 58,807 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Implantable Cardiac Monitors Market Analyzing CAGR 5.13% - openPR
Cardiac Resynchronization Therapy (CRT) Market Insights, Competitive Landscape and Market Forecast 2024-2030 - GlobeNewswire Inc.
BNP Paribas Financial Markets Reduces Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cerity Partners LLC Invests $573,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Holocene Advisors LP Raises Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Polar Asset Management Partners Inc. Buys New Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Pacemakers Market to Witness Massive Growth with Medtronic, LivaNova, Medico - openPR
LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting - sharewise
Redmile Group LLC Sells 54,467 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cardiac Rhythm Management Devices Market: Holistic Growth - openPR
Thrivent Financial for Lutherans Has $670,000 Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present Breakthrough Epilepsy Treatment Research at Major AES 2024 Conference - StockTitan
Parkman Healthcare Partners LLC Grows Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
NFJ Investment Group LLC Has $5.07 Million Stock Holdings in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
11,735 Shares in LivaNova PLC (NASDAQ:LIVN) Acquired by Martingale Asset Management L P - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Receives $69.17 Consensus Target Price from Analysts - MarketBeat
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):